A unique, low dose of intravenous enoxaparin in elective percutaneous coronary intervention.
about
Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysisCatheter thrombosis during primary percutaneous coronary intervention for acute ST elevation myocardial infarction despite subcutaneous low-molecular-weight heparin, acetylsalicylic acid, clopidogrel and abciximab pretreatmentRecommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction.Low-molecular-weight heparins in the cardiac catheterization laboratoryRelative antithrombotic and antihemostatic effects of protein C activator versus low-molecular-weight heparin in primates.Changing roles of anticoagulant and antiplatelet treatment during percutaneous coronary intervention.Anti-factor Xa kinetics after intravenous enoxaparin in patients undergoing percutaneous coronary intervention: a population model analysis.Role of low-molecular-weight heparin in invasive management of non-ST-elevation acute coronary syndromes.Anticoagulation monitoring part 2: Unfractionated heparin and low-molecular-weight heparin.Newer pharmacotherapy in patients undergoing percutaneous coronary interventions: a guide for pharmacists and other health care professionals.Pharmacological antithrombotic adjuncts to percutaneous coronary intervention.Safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and InterventiAnticoagulation in coronary intervention.Comparison of anti-Xa activity after a single intravenous bolus of low-dose enoxaparin in patients with and without end-stage renal disease.The Angio-Seal arterial closure device for early ambulation after elective percutaneous coronary intervention in patients receiving low-dose enoxaparin.High-dose intravenous dalteparin can be monitored effectively using standard coagulation times.Anticoagulation after subcutaneous enoxaparin is time sensitive in STEMI patients treated with tenecteplase.
P2860
Q26853150-7E4261A3-CCEB-4749-B75E-FCF50E6EDD5BQ28217792-35F76D51-2E3E-4521-9F1C-8086C3AA765DQ35582491-3339A370-2383-4CF0-AE73-449F846EF5A1Q35733959-E2E312AD-1F26-482E-8F22-0C0FD8E544DDQ35804490-8150865C-FD5C-44D9-A638-EB54D56AB3E7Q35808289-80A62D46-5DEA-42D1-949D-70FD6B73E965Q35826954-97A06227-D4E1-4A72-A8B1-FE6D66AAF922Q35944733-D72F24F9-0B93-417F-A338-453FA88F5769Q36163207-E54805B8-317E-4FB0-A423-136B9BA2920FQ36634214-6B52E14A-C975-4A90-A745-2E5F60CF9DE7Q36787291-86D63738-4A65-4333-BADA-62C09EF96EEAQ37178035-1533B7AC-6C64-4A1F-B9DE-39888B20A9A6Q37953885-5F51CB73-B836-4199-82D6-BECC9B201C73Q38762278-F3FA2ECD-7E29-42CB-AEB3-550E00293209Q43166177-F9AE0725-9047-4CFF-B8C5-716B55F9436BQ46334556-79E41418-F8C7-4E6A-B27D-30BA42C847B5Q46431021-FD7923E2-12FA-435C-BB80-64B97DD59040Q53656617-533CD0C5-7CD1-4B8C-A68B-DA847ADF50E0
P2860
A unique, low dose of intravenous enoxaparin in elective percutaneous coronary intervention.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
A unique, low dose of intraven ...... taneous coronary intervention.
@en
A unique, low dose of intraven ...... taneous coronary intervention.
@nl
type
label
A unique, low dose of intraven ...... taneous coronary intervention.
@en
A unique, low dose of intraven ...... taneous coronary intervention.
@nl
prefLabel
A unique, low dose of intraven ...... taneous coronary intervention.
@en
A unique, low dose of intraven ...... taneous coronary intervention.
@nl
P2093
P50
P1476
A unique, low dose of intraven ...... taneous coronary intervention.
@en
P2093
Annick Ankri
Daniel Thomas
Eric Vicaut
Ivan Sotirov
Jean Philippe Collet
Vanessa Gallois
P304
P356
10.1016/S0735-1097(02)02531-7
P407
P577
2002-12-01T00:00:00Z